Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision marker updated from v3.6.2 to v3.6.3, signaling a new page release. No study details or primary information appear to be altered.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update appears to be a backend/content-management change rather than a substantive modification to the study details or eligibility criteria.SummaryDifference0.0%

- Check41 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and recruitment status now shows 'No longer looking for participants'. The Intervention header was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check48 days agoChange DetectedUpdated the location list by replacing Kharkivs’ka Oblast’ with Kharkiv Oblast and adding the detailed location entry for Kharkiv, Kharkiv Oblast, Ukraine, 61070. Revision updated from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a recent backend/software update behind the scenes.SummaryDifference0.0%

- Check77 days agoChange DetectedThe Taiwan site entry in the locations list was revised from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.